Open AccessDetermination of CEBPA mutations by next generation sequencing in pediatric acute leukemia
Author(s) -
Dilara Fatma Akın,
Deniz Aşlar Öner,
Emin Kürekçi,
Nejat Akar
Publication year - 2018
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2018_068
Subject(s) - cebpa , kras , missense mutation , npm1 , mutation , biology , cancer research , gene , leukemia , genetics , medicine , karyotype , chromosome
The CCAAT/enhancer-binding protein-alpha (CEBPA) is lineage-specific transcription factor in the hematopoietic system. In this study, we aimed on the clinical features and the prognostic significance associated with CEBPA mutations in 30 pediatric patients with acute leukemia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom